|
|
|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
| |
KEQU's Capital Expenditures Growth by Quarter and Year
Kewaunee Scientific's Capital Expenditures results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Capital Expenditures Growth Y/Y▼
|
Capital Expenditures Growth Y/Y▼
|
| KEQU Capital Expenditures (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
April |
0.52
|
0.98
|
2.59
|
0.69
|
| 3rd Quarter |
January |
0.69
|
0.48
|
0.64
|
0.29
|
| 2nd Quarter |
October |
0.68
|
1.27
|
0.53
|
0.45
|
| 1st Quarter |
July |
0.28
|
1.65
|
0.39
|
0.48
|
| FY |
|
2.17
|
4.38
|
4.15
|
1.91
|
| KEQU Capital Expenditures fourth quarter 2025 Y/Y Growth Comment |
Kewaunee Scientific Corporation reported drop in Capital Expenditures in the fourth quarter 2025 by -47.35% to $ 0.52 millions, from the same quarter in 2024.
The fall in the fourth quarter 2025 Kewaunee Scientific Corporation's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures rise of 26.44%.
Looking into fourth quarter 2025 results within Laboratory Analytical Instruments industry 13 other companies have achieved higher Capital Expenditures growth. While Kewaunee Scientific Corporation' s Capital Expenditures meltdown of -47.35% ranks overall at the positon no. 2514 in the fourth quarter 2025.
|
| KEQU Capital Expenditures ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
April |
-47.35 % |
-62.16 % |
275.36 % |
53.33 % |
| 3rd Quarter |
January |
43.75 % |
-25 % |
120.69 % |
-55.38 % |
| 2nd Quarter |
October |
-46.46 % |
139.62 % |
17.78 % |
21.62 % |
| 1st Quarter |
July |
-83.03 % |
323.08 % |
-18.75 % |
-47.83 % |
| FY |
|
-50.55 % |
5.54 % |
117.28 % |
-20.08 % |
KEQU Capital Expenditures (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
April |
-25.22 % |
104.17 % |
304.69 % |
137.93 % |
| 3rd Quarter |
January |
1.47 % |
-62.2 % |
20.75 % |
-35.56 % |
| 2nd Quarter |
October |
142.86 % |
-23.03 % |
35.9 % |
-6.25 % |
| 1st Quarter |
July |
-71.43 % |
-36.29 % |
-43.48 % |
6.67 % |
| FY (Year on Year) |
|
-50.55 % |
5.54 % |
117.28 % |
-20.08 % |
| Capital Expenditures Y/Y Growth Statistics |
| High |
Average |
Low |
| 324.1 % |
26.44 % |
-100 % |
|
|
|
|
|
| Capital Expenditures Y/Y Growth Statistics |
| High |
Average |
Low |
| 324.1 % |
26.44 % |
-100 % |
|
|
|
|
| Capital Expenditures by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Kewaunee Scientific's Q/Q Capital Expenditures Growth
| Capital Expenditures Q/Q Growth Statistics |
| High |
Average |
Low |
| 302.18 % |
11.79 % |
-100 % |
| (Apr 30 2023) |
|
|
| KEQU's IV. Quarter Q/Q Capital Expenditures Comment |
In the IV. Quarter 2025 Kewaunee Scientific Corporation disclosed fall in Capital Expenditures from the third quarter by -25.22% to $ 0.52 millions, from $ 0.69 millions achived in the previous reporting period.
Although periodic circumstance commonly energize IV. Quarter 2025 Capital Expenditures, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.
Within Laboratory Analytical Instruments industry 10 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Kewaunee Scientific's Capital Expenditures growth quarter on quarter, overall rank is 1962. |
|
|
|
| Capital Expenditures Q/Q Growth Statistics |
| High |
Average |
Low |
| 302.18 % |
11.79 % |
-100 % |
| (Apr 30 2023) |
|
|
| KEQU's IV. Quarter Q/Q Capital Expenditures Comment |
In the IV. Quarter 2025 Kewaunee Scientific Corporation disclosed fall in Capital Expenditures from the third quarter by -25.22% to $ 0.52 millions, from $ 0.69 millions achived in the previous reporting period.
Although periodic circumstance commonly energize IV. Quarter 2025 Capital Expenditures, this plainly could not be substantial to rescue Laboratory Analytical Instruments's company achievement, Most analysts pointed out.
Within Laboratory Analytical Instruments industry 10 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Kewaunee Scientific's Capital Expenditures growth quarter on quarter, overall rank is 1962. |
|
Kewaunee Scientific's 12 Months Capital Expenditures Growth Year on Year
Capital Expenditures TTM Growth |
12 Months Ending
(Apr 30 2025) |
12 Months Ending
(Jan 31 2025) |
12 Months Ending
(Oct 31 2024) |
12 Months Ending
(Jul 31 2024) |
12 Months Ending
(Apr 30 2024) |
| Cumulative Capital Expenditures 12 Months Ending |
$ 2.17 |
$ 2.63 |
$ 2.42 |
$ 3.00 |
$ 4.37 |
| Y / Y Capital Expenditures Growth (TTM) |
-50.47 % |
-56.04 % |
-60.72 % |
-44.62 % |
5.42 % |
| Year on Year Capital Expenditures Growth Overall
Ranking |
# 2335 |
# 2394 |
# 2258 |
# 2009 |
# 1133 |
| Seqeuential Capital Expenditures Change (TTM) |
-17.61 % |
8.86 % |
-19.42 % |
-31.47 % |
-26.87 % |
| Seq. Capital Expenditures Growth (TTM) Overall
Ranking |
# 2335 |
# 2394 |
# 2258 |
# 2009 |
# 1133 |
| Cumulative Capital Expenditures growth Comment |
Kewaunee Scientific showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Jan 31 2025. If the fiscal year would end in Apr 30 2025, Kewaunee Scientific's annual Capital Expenditures drop would be -50.47% year on year to $2 millions.
In the Healthcare sector 130 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 2335, from total ranking in previous quarter at 2394. |
|
|
| Capital Expenditures TTM Y/Y Growth Statistics |
| High |
Average |
Low |
224.09 % |
13.44 % |
-60.72 % |
| (Oct 31 2023) |
|
|
| Capital Expenditures TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 8 |
| Sector |
# 218 |
| S&P 500 |
# 1960 |
|
| Cumulative Capital Expenditures growth
Comment |
Kewaunee Scientific showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Jan 31 2025. If the fiscal year would end in Apr 30 2025, Kewaunee Scientific's annual Capital Expenditures drop would be -50.47% year on year to $2 millions.
In the Healthcare sector 130 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 2335, from total ranking in previous quarter at 2394. |
| Capital Expenditures TTM Y/Y Growth Statistics |
| High |
Average |
Low |
224.09 % |
13.44 % |
-60.72 % |
| (Oct 31 2023) |
|
|
| Capital Expenditures TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 8 |
| Sector |
# 218 |
| S&P 500 |
# 1960 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
